
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 7.430 | 7.430 | 0.000 |
Shares | 92.630 | 92.630 | 0.000 |
Bonds | 4.680 | 4.680 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 32.302 | 34.289 |
Price to Book | 5.877 | 4.383 |
Price to Sales | 8.836 | 6.568 |
Price to Cash Flow | 26.525 | 25.092 |
Dividend Yield | 0.670 | 1.464 |
5 Years Earnings Growth | 2.280 | 6.365 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 93.370 | 93.904 |
Consumer Defensive | 6.620 | 4.796 |
Technology | 0.010 | 0.623 |
Number of long holdings: 76
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Innovent Biologics | KYG4818G1010 | 8.33 | 100.50 | +2.60% | |
Sichuan Kelun Biotech | CNE1000062J1 | 8.15 | 561.50 | 0.00% | |
Jiangsu Hengrui | CNE0000014W7 | 8.08 | 71.55 | +3.40% | |
Akeso | KYG0146B1032 | 8.07 | 141.30 | +1.07% | |
CSPC Innovation | CNE100003K04 | 6.13 | 45.92 | -1.18% | |
Sichuan Biokin Pharmaceutical | CNE100006FN4 | 5.99 | 375.30 | +3.43% | |
BeOne Medicines | CNE100005XT6 | 5.97 | 306.90 | +1.95% | |
Hansoh Pharmaceutical Group | KYG549581067 | 4.15 | 38.74 | +0.47% | |
RemeGen | CNE100005B03 | 4.05 | 116.88 | +6.25% | |
Keymed Biosciences Inc | - | 3.91 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
BOC Income Mixed Securities Inves A | 1.96B | 35.35 | 4.75 | 11.41 | ||
BOC Income Mixed Securities Inves H | 1.96B | 35.34 | 4.76 | - | ||
BOC Thematic Strategy Stock | 1.58B | 37.22 | 5.44 | 10.84 | ||
BOC Sustainable Growth MixSec inv A | 1.33B | 24.74 | -2.81 | 5.93 | ||
BOC Sustain Growth Mixed Sec inv H | 1.33B | 24.62 | -2.86 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review